Nakase, Hiroshi
Uchino, Motoi
Shinzaki, Shinichiro
Matsuura, Minoru
Matsuoka, Katsuyoshi
Kobayashi, Taku
Saruta, Masayuki
Hirai, Fumihito
Hata, Keisuke
Hiraoka, Sakiko
Esaki, Motohiro
Sugimoto, Ken
Fuji, Toshimitsu
Watanabe, Kenji
Nakamura, Shiro
Inoue, Nagamu
Itoh, Toshiyuki
Naganuma, Makoto
Hisamatsu, Tadakazu
Watanabe, Mamoru
Miwa, Hiroto
Enomoto, Nobuyuki
Shimosegawa, Tooru
Koike, Kazuhiko
Article History
Received: 25 March 2021
Accepted: 25 March 2021
First Online: 22 April 2021
Compliance with ethical standards
:
: Any financial relationship with enterprises, businesses or academic institutions in the subject matter or materials discussed in the manuscript are listed as follows; (1) those from which the authors, the spouse, partner or immediate relatives of authors, have received individually any income, honoraria or any other types of remuneration; Abbvie, Kissei Pharmaceutical, Kyorin Pharmaceutical, Mitsubishi Tanabe Pharma, Janssen Pharmaceutical, Takeda Pharmaceutical, Pfizer, Celgene, EA Pharma, Zeria Pharmaceutical, Mochida Pharmaceutical, Nippon Kayaku, Daiichi Sankyo, JIMRO, Alfressa Pharma, Gilead Sciences, and (2) those from which the authors have received scholarship/research grant; Nippon Kayaku, Takeda Pharmaceutical, Otsuka Pharmaceutical, Eisai, EA Pharma, Hoya Group Pentax Medical, Abbvie, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Janssen Pharmaceutical, EA Pharma, JIMRO, Zeria Pharmaceutical, Pfizer, Alfressa Pharma, Boehringer Ingelheim, Celgene, Eli Lilly and Company, Gilead Sciences, Kissei Pharmaceutical, and (3) those from which the authors have received individually endowed chair; Mitsubishi Tanabe Pharma, EA Pharma, AbbVie, Janssen Pharmaceutical, Mochida Pharmaceutical, Takeda Pharmaceutical, Kyorin Holdings, JIMRO, Zeria Pharmaceutical, Otsuka Pharmaceutical.
: The members of the Guidelines Committee who created and evaluated the JSGE “Evidence-based clinical practice guidelines for inflammatory bowel disease” are listed below.
: Chair: Mamoru Watanabe (Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University). Vice-Chair: Hiroshi Nakase (Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine). Members: Motoi Uchino (Department of Inflammatory Bowel Disease, Hyogo College of Medicine, Nishinomiya), Shinichiro Shinzaki (Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine), Minoru Matsuura (Department of Gastroenterology and Hepatology, Kyorin University School of Medicine), Katsuyoshi Matsuoka (Department of Gastroenterology and Hepatology, Toho University Sakura Medical Center), Taku Kobayashi (Center for Advanced IBD Research and Treatment, Kitasato University, Kitasato Institute Hospital), Masayuki Saruta (Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine), Fumihito Hirai (Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine), Keisuke Hata (Department of Surgical Oncology, The University of Tokyo), Sakiko Hiraoka (Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences), Motohiro Esaki (Department of Endoscopic Diagnostics and Therapeutics, Saga University Hospital), Ken Sugimoto (First Department of Medicine, Hamamatsu University School of Medicine), Toshimitsu Fuji (Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University), Kenji Watanabe (Center for Inflammatory Bowel Disease, Division of Internal Medicine, Hyogo College of Medicine), Shiro Nakamura (Department of Internal Medicine II, Osaka Medical College Hospital), Nagamu Inoue (Centers for Preventive Medicine, Keio University School of Medicine).
: Chair: Tadakazu Hisamatsu (Department of Gastroenterology and Hepatology, Kyorin University School of Medicine). Vice-Chair: Toshiyuki Itoh (Education Center for Medicine and Nursing, Undergraduate School of Medicine, Shiga University of Medical Science). Members: Makoto Naganuma (The Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University).
: President: Kazuhiko Koike (Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo). Past President: Tooru Shimosegawa (South MiyagiMedical Center). Director Responsible: Hiroto Miwa (Division of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine), Nobuyuki Enomoto (First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi).